Earnings Preview: Tarsus Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Tarsus Pharmaceuticals (NASDAQ:TARS) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-1.36. The company's stock price often reacts to its earnings guidance. Last quarter, TARS missed EPS by $0.09, resulting in a 1.12% drop in share price. The company's shares were trading at $16.07 as of November 7, with a 52-week return of -9.6%.
November 08, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Tarsus Pharmaceuticals is expected to report an EPS of $-1.36 in its upcoming earnings. The company's stock price often reacts to its earnings guidance. Last quarter, TARS missed EPS by $0.09, resulting in a 1.12% drop in share price.
Tarsus Pharmaceuticals' stock price is likely to be impacted by its upcoming earnings report. The company's past performance shows that its stock price often reacts to its earnings guidance. Last quarter, when the company missed its EPS estimate, its stock price dropped by 1.12%. Given that analysts are predicting an EPS of $-1.36 for the upcoming quarter, a similar miss could potentially lead to another drop in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100